MediWound 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
36 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NexoBrid (bromelain) / MediWound, Kaken Pharma, Teva
NCT04468139: The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19

Recruiting
4
60
RoW
Quercetin, bromelain, Zinc, Vitamin C
Ministry of Health, Saudi Arabia
Covid-19
07/20
07/20
NCT04669119: Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy.

Recruiting
4
120
Europe
Bromelain/Boswellia Serrata Casperome, Centella Asiatica/Vitamins, Placebo
University of Bari Aldo Moro
Breast Cancer Female, Pain, Postoperative
12/21
01/22
2020-003154-80: Study of the mechanism of action of a medicinal product based on Bromelain, Trypsin and Rutoside, compared to the same medicinal product without active ingredient called Placebo in subjects suffering from osteoarthritis. Étude du mécanisme d'action d'un médicament à base de Broméline, de Trypsine et de Rutoside, comparé au même médicament sans ingrédient actif appelé Placebo chez des sujets souffrant d'arthrose.

Not yet recruiting
4
40
Europe
Wobenzym, Gastro-resistant tablet, WOBENZYM®, enteric-coated tablet
Mucos Pharma GmbH & Co. KG, Mucos Pharma GmbH & Co. KG
Subjects suffering from knee Osteoarthitis Sujets souffrant d'Arthrose du genou, Subjects suffering from knee osteoarthritis Sujets souffrant d'arthrose du genou, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2005-002369-35: Reduction of pain under pressure of an experimentally induced hematoma in healthy volunteers by two Bromelain preparations (Bromelain-POS(R) and Traumanase(R) forte).

Ongoing
3
68
Europe
Bromelain-POS(R), Traumanase(R) forte, Bromelain-POS(R), Traumanase(R) forte, Bromelain-POS(R), Traumanase(R) forte
Ursapharm Arzneimittel GmbH&Co. KG
healthy subjects
 
 
NCT02278718 / 2014-003066-24: A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care

Completed
3
145
Europe, US, RoW
NexoBrid, Standard of Care
MediWound Ltd
Thermal Burns
04/21
12/22
NCT05681312: Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars

Recruiting
3
55
RoW
systemic proteolytic enzyme (Tibrolin), tibrolin, Amoxicillin 500mg+metronidazole 500mg+ doliprane 100mg
University of Baghdad
Post Operative Pain
09/24
09/24
VALUE, NCT06568627: A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU

Not yet recruiting
3
216
NA
EscharEx (EX-03), EX-03, Placebo (Gel vehicle), Gel vehicle
MediWound Ltd
Venous Leg Ulcer (VLU)
10/26
10/26
2020-005523-37: A prospective controlled proof-of-concept trial to demonstrate anti-viral effects of oral bromelaine in COVID-19 positive patients

Ongoing
2
150
Europe
Gastro-resistant tablet, Bromelaintabletten hysan, 500 F.I.P.-Einheiten, magensaftresistente Tabletten
URSAPHARM Arzneimittel GmbH, URSAPHARM Arzneimittel GmbH
Diagnosis of SARS-CoV-2 infection documented by a positive PCR test, Diagnosis of SARS-CoV-2 infection documented by a positive PCR test, Diseases [C] - Virus Diseases [C02]
 
 
NCT05349929: Analgesic Effect of Anahil and Ibuprofen on Pain After Root Canal Therapy in Patients With Pulpitis of the Molars in Qazvin(a City in Iran)

Not yet recruiting
2
72
NA
Gelofen (generic name of Ibuprofen in Iran), Anahil ( generic name of Bromelain in Iran), Root Canal Therapy
Qazvin University Of Medical Sciences
Irreversible Pulpitis
11/22
12/22
NCT03976973: BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Not yet recruiting
2
62
NA
Bromelain, Acetylcysteine, Interventional radiology insertion of drain
Mucpharm Pty Ltd, Mercy Medical Center, Wake Forest University Health Sciences, University of Pittsburgh Medical Center, Catharina Ziekenhuis Eindhoven, Hospital Universitario Reina Sofia de Cordoba
Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma, Mucinous Tumor
11/23
02/24
PROSTA-Q, NCT04252625: Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis

Terminated
2
10
US
Q-Urol, Placebo
University of Utah, Farr Labs, LLC
Prostate Adenocarcinoma
12/23
01/24
VLU, NCT06690177: Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Not yet recruiting
2
45
Europe, US
EscharEx (EX-03), Placebo (Gel vehicle)
MediWound Ltd
Venus Leg Ulcers
12/27
09/28
ACTRN12620001209987p: Dose Determination and Safety Evaluation of the Gastrointestinal ReProgramming (GaRP) Dietary supplement in diarrhoea predominant Irritable Bowel Syndrome patients

Not yet recruiting
1/2
200
 
Anatara Lifesciences, Anatara Lifesciences
Irritable Bowel Syndrome - diarrhoea predominant
 
 
ACTRN12617001612303: Injection of Bromelain and Acetylcysteine in combination into recurrent mucinous tumour or pseudomyxoma peritonei: a phase I/II study

Recruiting
1/2
60
 
Professor David Morris , Department of Surgery, St George Hospital, MUCPharm Pty Ltd
pseudomyxoma peritonei, recurrent pseudomyxoma peritonei , peritoneal disease , low grade appendix tumour
 
 
ACTRN12620001209987: Dose Determination and Efficacy Evaluation of the Gastrointestinal ReProgramming (GaRP) Dietary supplement in Irritable Bowel Syndrome patients

Recruiting
1/2
200
 
Anatara Lifesciences, Anatara Lifesciences
Irritable Bowel Syndrome
 
 
NCT05258682: Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease

Not yet recruiting
1/2
30
NA
Bromelains, Bromelain, Acetylcysteine, N-Acetylcysteine
Mucpharm Pty Ltd, St George Hospital, Australia
COVID-19 Pneumonia, COVID-19, Ventilator Associated Pneumonia, COVID-19 Acute Respiratory Distress Syndrome
09/22
10/22
NCT05000983: A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries

Recruiting
1/2
25
Canada
PluroGel, Standard dressing
University of Manitoba, Medline Industries
Burns
11/26
12/27
NCT04893863: A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries

Recruiting
1/2
20
Canada
Standard dressing, PluroGel
University of Manitoba
Burns
12/26
06/27
ACTRN12622000022763p: Safety of nebulised delivery of BromAc® (Bromelain & Acetylcysteine) in healthy volunteers: a potential treatment for severe COVID-19

Not yet recruiting
1
12
 
Mucpharm Pty Ltd , Mucpharm Pty Ltd
COVID-19
 
 
ACTRN12620000788976: Safety and efficacy of intranasal delivery of BromAc® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients

Recruiting
1
40
 
Mucpharm Pty Ltd, Mucpharm Pty Ltd
SARS-CoV-2, COVID19
 
 
NCT04982146: Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Active, not recruiting
1
10
Europe
Bromelin, N-Acetylcysteine
Maimónides Biomedical Research Institute of Córdoba
Pseudomyxoma Peritonei
05/22
05/23
ACTRN12622000022763: Safety of nebulised delivery of BromAc® (Bromelain & Acetylcysteine) in healthy volunteers: a potential treatment for severe COVID-19

Completed
1
12
 
Mucpharm Pty Ltd , Mucpharm Pty Ltd
COVID-19
 
 
NCT05687760: Effect of Bromelain Versus Calcium Hydroxide as an Intracanal Medication on the Intensity of Postoperative Pain and Bacterial Load Reduction in Necrotic Single Rooted Lower Premolars

Not yet recruiting
1
30
NA
bromelain, Calcium hydroxide
Cairo University
Intracanal Medication, Bromelain, Calcium Hydroxide, Bacterial Load Reduction
02/23
02/23
NCT06775392: Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing In Stage I /II and Grade B Periodontitis - Randomized Control Clinical Trail

Completed
1
30
RoW
bromelain-quercetin gel, chlorhexidine gel, SRP
Krishnadevaraya College of Dental Sciences & Hospital
Periodontal Pocket
08/24
08/24
NCT06505759: Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT

Recruiting
1
36
RoW
Bromelain gel, chlorhexidine gel, SRP
Krishnadevaraya College of Dental Sciences & Hospital
Periodontal Pocket
07/25
07/25
NCT04040660: Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries

Approved for marketing
N/A
US
NexoBrid
MediWound Ltd
Thermal Burn
 
 
ChiCTR2000039327: Study on evidence-based evaluation and therapeutic mechanism of integrated Chinese and Western medicine for treatment of diabetic foot -- An evidence-based evaluation of The combination of Rubber Shengji Paste and compound bromelain to promote the healing of the exposed wound of diabetic foot tendon

Recruiting
N/A
360
 
Routine basic medical and surgical treatment ;For external use, compound bromelain + Rubber muscle cream ;Routine basic medical and surgical treatment ;Debridement adhesive dressing
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, National key research and development plan funding support
Diabetic foot
 
 
NCT05520411: Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension

Completed
N/A
25
US
HUM Flatter Me
HUM Nutrition, Inc., Citruslabs
Stomach Distended, Bloating
01/23
01/23
AАBA, NCT06142994: Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting

Completed
N/A
310
Europe
Atusin CAP, Placebo
Neopharm Bulgaria Ltd.
Acute Bronchitis
06/24
06/24
NCT06516744: A Single Group Study to Evaluate the Efficacy of Bye Bye Bloat Capsules in Relieving Bloating and Promoting Healthy Digestion.

Completed
N/A
40
US
Bye Bye Bloat Capsules
Love Wellness, Citruslabs
Digestive Health, Digestion
04/24
04/24
NCT06298383: The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain

Not yet recruiting
N/A
120
NA
Trypsin, Bromelain and Rutoside, Flamogen, Diclofenac Potassium, Cataflam, Prednisolone Oral Tablet, solupred, Placebo
Cairo University, Egyptian Russian University
Symptomatic Irreversible Pulpitis
07/24
09/24
NCT06351696: The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

Recruiting
N/A
84
RoW
Bromlein, Placebo
National Nutrition and Food Technology Institute
Ulcerative Colitis, Primary Sclerosing Cholangitis
07/24
08/24
NCT05879406: A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne

Recruiting
N/A
40
US
VitaMedica® Clear Skin Formula capsules, Placebo Capsules
Ablon Skin Institute Research Center, Grove Acquisition Subsidiary dba VitaMedica
Non-Cystic Acne
05/24
05/24
NCT06363721: A Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental Health

Recruiting
N/A
18
US
PerioPull™
Designs for Health
Oral Health
12/24
12/24
ACTRN12617000207314: “Quercetin as an augmentation agent in Treatment Resistant Schizophrenia”

Recruiting
N/A
20
 
University of Western Australia School of Medicine and Pharmacology, Graylands Hospital, University of Western Australia, Bioceuticals
schizophrenia
 
 
ACTRN12622000520730: A pilot study assessing the feasibility of NexoBrid versus the current standard of care of isolated upper limb burns: A solution to “the perfect crime”?

Terminated
N/A
20
 
Royal Brisbane and Women's Hospital, RBWH Foundation Burns Research Grant 2022
Burns
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NexoBrid (bromelain) / MediWound, Kaken Pharma, Teva
NCT04468139: The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19

Recruiting
4
60
RoW
Quercetin, bromelain, Zinc, Vitamin C
Ministry of Health, Saudi Arabia
Covid-19
07/20
07/20
NCT04669119: Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy.

Recruiting
4
120
Europe
Bromelain/Boswellia Serrata Casperome, Centella Asiatica/Vitamins, Placebo
University of Bari Aldo Moro
Breast Cancer Female, Pain, Postoperative
12/21
01/22
2020-003154-80: Study of the mechanism of action of a medicinal product based on Bromelain, Trypsin and Rutoside, compared to the same medicinal product without active ingredient called Placebo in subjects suffering from osteoarthritis. Étude du mécanisme d'action d'un médicament à base de Broméline, de Trypsine et de Rutoside, comparé au même médicament sans ingrédient actif appelé Placebo chez des sujets souffrant d'arthrose.

Not yet recruiting
4
40
Europe
Wobenzym, Gastro-resistant tablet, WOBENZYM®, enteric-coated tablet
Mucos Pharma GmbH & Co. KG, Mucos Pharma GmbH & Co. KG
Subjects suffering from knee Osteoarthitis Sujets souffrant d'Arthrose du genou, Subjects suffering from knee osteoarthritis Sujets souffrant d'arthrose du genou, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2005-002369-35: Reduction of pain under pressure of an experimentally induced hematoma in healthy volunteers by two Bromelain preparations (Bromelain-POS(R) and Traumanase(R) forte).

Ongoing
3
68
Europe
Bromelain-POS(R), Traumanase(R) forte, Bromelain-POS(R), Traumanase(R) forte, Bromelain-POS(R), Traumanase(R) forte
Ursapharm Arzneimittel GmbH&Co. KG
healthy subjects
 
 
NCT02278718 / 2014-003066-24: A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care

Completed
3
145
Europe, US, RoW
NexoBrid, Standard of Care
MediWound Ltd
Thermal Burns
04/21
12/22
NCT05681312: Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars

Recruiting
3
55
RoW
systemic proteolytic enzyme (Tibrolin), tibrolin, Amoxicillin 500mg+metronidazole 500mg+ doliprane 100mg
University of Baghdad
Post Operative Pain
09/24
09/24
VALUE, NCT06568627: A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU

Not yet recruiting
3
216
NA
EscharEx (EX-03), EX-03, Placebo (Gel vehicle), Gel vehicle
MediWound Ltd
Venous Leg Ulcer (VLU)
10/26
10/26
2020-005523-37: A prospective controlled proof-of-concept trial to demonstrate anti-viral effects of oral bromelaine in COVID-19 positive patients

Ongoing
2
150
Europe
Gastro-resistant tablet, Bromelaintabletten hysan, 500 F.I.P.-Einheiten, magensaftresistente Tabletten
URSAPHARM Arzneimittel GmbH, URSAPHARM Arzneimittel GmbH
Diagnosis of SARS-CoV-2 infection documented by a positive PCR test, Diagnosis of SARS-CoV-2 infection documented by a positive PCR test, Diseases [C] - Virus Diseases [C02]
 
 
NCT05349929: Analgesic Effect of Anahil and Ibuprofen on Pain After Root Canal Therapy in Patients With Pulpitis of the Molars in Qazvin(a City in Iran)

Not yet recruiting
2
72
NA
Gelofen (generic name of Ibuprofen in Iran), Anahil ( generic name of Bromelain in Iran), Root Canal Therapy
Qazvin University Of Medical Sciences
Irreversible Pulpitis
11/22
12/22
NCT03976973: BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Not yet recruiting
2
62
NA
Bromelain, Acetylcysteine, Interventional radiology insertion of drain
Mucpharm Pty Ltd, Mercy Medical Center, Wake Forest University Health Sciences, University of Pittsburgh Medical Center, Catharina Ziekenhuis Eindhoven, Hospital Universitario Reina Sofia de Cordoba
Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma, Mucinous Tumor
11/23
02/24
PROSTA-Q, NCT04252625: Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis

Terminated
2
10
US
Q-Urol, Placebo
University of Utah, Farr Labs, LLC
Prostate Adenocarcinoma
12/23
01/24
VLU, NCT06690177: Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Not yet recruiting
2
45
Europe, US
EscharEx (EX-03), Placebo (Gel vehicle)
MediWound Ltd
Venus Leg Ulcers
12/27
09/28
ACTRN12620001209987p: Dose Determination and Safety Evaluation of the Gastrointestinal ReProgramming (GaRP) Dietary supplement in diarrhoea predominant Irritable Bowel Syndrome patients

Not yet recruiting
1/2
200
 
Anatara Lifesciences, Anatara Lifesciences
Irritable Bowel Syndrome - diarrhoea predominant
 
 
ACTRN12617001612303: Injection of Bromelain and Acetylcysteine in combination into recurrent mucinous tumour or pseudomyxoma peritonei: a phase I/II study

Recruiting
1/2
60
 
Professor David Morris , Department of Surgery, St George Hospital, MUCPharm Pty Ltd
pseudomyxoma peritonei, recurrent pseudomyxoma peritonei , peritoneal disease , low grade appendix tumour
 
 
ACTRN12620001209987: Dose Determination and Efficacy Evaluation of the Gastrointestinal ReProgramming (GaRP) Dietary supplement in Irritable Bowel Syndrome patients

Recruiting
1/2
200
 
Anatara Lifesciences, Anatara Lifesciences
Irritable Bowel Syndrome
 
 
NCT05258682: Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease

Not yet recruiting
1/2
30
NA
Bromelains, Bromelain, Acetylcysteine, N-Acetylcysteine
Mucpharm Pty Ltd, St George Hospital, Australia
COVID-19 Pneumonia, COVID-19, Ventilator Associated Pneumonia, COVID-19 Acute Respiratory Distress Syndrome
09/22
10/22
NCT05000983: A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries

Recruiting
1/2
25
Canada
PluroGel, Standard dressing
University of Manitoba, Medline Industries
Burns
11/26
12/27
NCT04893863: A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries

Recruiting
1/2
20
Canada
Standard dressing, PluroGel
University of Manitoba
Burns
12/26
06/27
ACTRN12622000022763p: Safety of nebulised delivery of BromAc® (Bromelain & Acetylcysteine) in healthy volunteers: a potential treatment for severe COVID-19

Not yet recruiting
1
12
 
Mucpharm Pty Ltd , Mucpharm Pty Ltd
COVID-19
 
 
ACTRN12620000788976: Safety and efficacy of intranasal delivery of BromAc® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients

Recruiting
1
40
 
Mucpharm Pty Ltd, Mucpharm Pty Ltd
SARS-CoV-2, COVID19
 
 
NCT04982146: Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Active, not recruiting
1
10
Europe
Bromelin, N-Acetylcysteine
Maimónides Biomedical Research Institute of Córdoba
Pseudomyxoma Peritonei
05/22
05/23
ACTRN12622000022763: Safety of nebulised delivery of BromAc® (Bromelain & Acetylcysteine) in healthy volunteers: a potential treatment for severe COVID-19

Completed
1
12
 
Mucpharm Pty Ltd , Mucpharm Pty Ltd
COVID-19
 
 
NCT05687760: Effect of Bromelain Versus Calcium Hydroxide as an Intracanal Medication on the Intensity of Postoperative Pain and Bacterial Load Reduction in Necrotic Single Rooted Lower Premolars

Not yet recruiting
1
30
NA
bromelain, Calcium hydroxide
Cairo University
Intracanal Medication, Bromelain, Calcium Hydroxide, Bacterial Load Reduction
02/23
02/23
NCT06775392: Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing In Stage I /II and Grade B Periodontitis - Randomized Control Clinical Trail

Completed
1
30
RoW
bromelain-quercetin gel, chlorhexidine gel, SRP
Krishnadevaraya College of Dental Sciences & Hospital
Periodontal Pocket
08/24
08/24
NCT06505759: Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT

Recruiting
1
36
RoW
Bromelain gel, chlorhexidine gel, SRP
Krishnadevaraya College of Dental Sciences & Hospital
Periodontal Pocket
07/25
07/25
NCT04040660: Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries

Approved for marketing
N/A
US
NexoBrid
MediWound Ltd
Thermal Burn
 
 
ChiCTR2000039327: Study on evidence-based evaluation and therapeutic mechanism of integrated Chinese and Western medicine for treatment of diabetic foot -- An evidence-based evaluation of The combination of Rubber Shengji Paste and compound bromelain to promote the healing of the exposed wound of diabetic foot tendon

Recruiting
N/A
360
 
Routine basic medical and surgical treatment ;For external use, compound bromelain + Rubber muscle cream ;Routine basic medical and surgical treatment ;Debridement adhesive dressing
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, National key research and development plan funding support
Diabetic foot
 
 
NCT05520411: Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension

Completed
N/A
25
US
HUM Flatter Me
HUM Nutrition, Inc., Citruslabs
Stomach Distended, Bloating
01/23
01/23
AАBA, NCT06142994: Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting

Completed
N/A
310
Europe
Atusin CAP, Placebo
Neopharm Bulgaria Ltd.
Acute Bronchitis
06/24
06/24
NCT06516744: A Single Group Study to Evaluate the Efficacy of Bye Bye Bloat Capsules in Relieving Bloating and Promoting Healthy Digestion.

Completed
N/A
40
US
Bye Bye Bloat Capsules
Love Wellness, Citruslabs
Digestive Health, Digestion
04/24
04/24
NCT06298383: The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain

Not yet recruiting
N/A
120
NA
Trypsin, Bromelain and Rutoside, Flamogen, Diclofenac Potassium, Cataflam, Prednisolone Oral Tablet, solupred, Placebo
Cairo University, Egyptian Russian University
Symptomatic Irreversible Pulpitis
07/24
09/24
NCT06351696: The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

Recruiting
N/A
84
RoW
Bromlein, Placebo
National Nutrition and Food Technology Institute
Ulcerative Colitis, Primary Sclerosing Cholangitis
07/24
08/24
NCT05879406: A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne

Recruiting
N/A
40
US
VitaMedica® Clear Skin Formula capsules, Placebo Capsules
Ablon Skin Institute Research Center, Grove Acquisition Subsidiary dba VitaMedica
Non-Cystic Acne
05/24
05/24
NCT06363721: A Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental Health

Recruiting
N/A
18
US
PerioPull™
Designs for Health
Oral Health
12/24
12/24
ACTRN12617000207314: “Quercetin as an augmentation agent in Treatment Resistant Schizophrenia”

Recruiting
N/A
20
 
University of Western Australia School of Medicine and Pharmacology, Graylands Hospital, University of Western Australia, Bioceuticals
schizophrenia
 
 
ACTRN12622000520730: A pilot study assessing the feasibility of NexoBrid versus the current standard of care of isolated upper limb burns: A solution to “the perfect crime”?

Terminated
N/A
20
 
Royal Brisbane and Women's Hospital, RBWH Foundation Burns Research Grant 2022
Burns
 
 

Download Options